MD

The LGMD Community Celebrates Adoption of ICD-10 Diagnostic Codes for LGMD

Retrieved on: 
Wednesday, June 29, 2022 - 10:52pm
Department, Diagnosis, Department of Neurology, Xuanwu hospital, View, Patient, Neurology, TikTok, LinkedIn, Public policy, Research, Adoption, Muscular dystrophy, ALS, Prevalence, Awareness, Muscular Dystrophy Association, Degenerative disease, Organization, FAAN, Incidence, NEW, MDA, Twitter, Physician, LGMD, Medical device, Pharmaceutical industry, MSCI, Facebook, Instagram, MD

The implementation of these ICD-10 codes represents a culmination of two-years of collaborative efforts within the LGMD patient, clinical, and research communities.

Key Points: 
  • The implementation of these ICD-10 codes represents a culmination of two-years of collaborative efforts within the LGMD patient, clinical, and research communities.
  • These diagnostic codes will be fully implemented and ready for use starting this October.
  • This significant advance could well shorten the diagnostic odyssey for individuals with LGMD, facilitate the targeted care the community needs, and accelerate surveillance and epidemiological research.
  • This milestone is the culmination of over two years of collaborative efforts between LGMD advocacy organizations and leading LGMD clinicians and researchers.

ACCREDITATION COUNCIL FOR GRADUATE MEDICAL EDUCATION ANNOUNCES SPECIALTY DESIGNATION OF PUBLIC HEALTH AND GENERAL PREVENTIVE MEDICINE

Retrieved on: 
Wednesday, June 29, 2022 - 10:21pm
American College of Preventive Medicine, CEO, FACPM, Population, ACPM, General officer, Aviation medicine, Graduate medical education, National Medical Commission, Multimedia, Job, Public health, Health promotion, Environmental medicine, Accreditation, Health, Quality of life, Accreditation Council, Medicine, ACGME, American College, Fortis Healthcare, News, Physician, Dentistry, MD

WASHINGTON, June 29, 2022 /PRNewswire/ -- The American College of Preventive Medicine (ACPM) embraces the recent news from the Accreditation Council for Graduate Medical Education (ACGME) that Public Health and General Preventive Medicine will now be recognized as a distinct medical specialty.

Key Points: 
  • The three specialties initially under the broad umbrella of preventive medicine will now be recognized as distinct fields of practice Public Health and General Preventive Medicine, Occupational and Environmental Medicine and Aerospace Medicine
    WASHINGTON, June 29, 2022 /PRNewswire/ -- The American College of Preventive Medicine (ACPM) embraces the recent news from the Accreditation Council for Graduate Medical Education (ACGME) that Public Health and General Preventive Medicine will now be recognized as a distinct medical specialty.
  • This new designation firmly establishes Public Health and General Preventive Medicine (PH/GPM) as the ACGME-certified specialty for public health and preventive medicine physicians.
  • Residency training programs for Public Health and General Preventive Medicine will follow independent curricula aligning with a more focused set of guidelines from ACGME for training the next generation of public health and preventive medicine physician specialists.
  • "The American College of Preventive Medicine is proud to be the professional home for all physicians practicing in public health and specifically those boarded in preventive medicine," said Donna Grande, CEO of the American College of Preventive Medicine.

ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy

Retrieved on: 
Wednesday, June 29, 2022 - 9:05pm
FDA, Assistant, Patient, Sarcocystis neurona, Biopsy, Gamma-Aminobutyric acid, Research, Brain, GLOBE, COVID-19, Growth, CNS, GABA, Company, U.S. Securities and Exchange Commission, Lists of diseases, Seizure, Therapy, State University of New York Upstate Medical University, Particular, Doctor of Philosophy, Neurosurgery, Nasdaq, Quality of life, Temporal lobe epilepsy, Solution, MD, Security (finance), Epilepsy, Pharmaceutical industry

An estimated three million Americans have epilepsy, and 25 to 35 percent live with ongoing seizures despite dozens of approved drugs on the market.

Key Points: 
  • An estimated three million Americans have epilepsy, and 25 to 35 percent live with ongoing seizures despite dozens of approved drugs on the market.
  • The first stage of the trial is an open-label dose-escalation study in up to 10 patients with MTLE.
  • Our team is proud to partner with Neurona to support their Phase 1/2 clinical trial of what could potentially be a breakthrough regenerative cell therapy for MTLE.
  • ClearPoint Neuro is partnered with approximately 45 biologics/pharmaceutical companies and academic centers, providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

3Spine, Inc. Completes First US Surgeries

Retrieved on: 
Wednesday, June 29, 2022 - 8:30pm
Spinal stenosis, UC, Patient, Movement, Cayman Islands, Achievement, Research, Walking, RWE, ClinicalTrials.gov, Clinical trial, Technology, Center, Back pain, Hip, Sports medicine, Pi, MD, IDE, Spondylolisthesis, Dentistry, Greater Boston

3Spine's RWE study has been enrolling in the US since May 2021.

Key Points: 
  • 3Spine's RWE study has been enrolling in the US since May 2021.
  • Each patient was up and walking within 2 hours after surgery, using the early mobilization protocols for hip and knee arthroplasty patients.
  • 3Spine is a new kind of healthcare company founded to integrate the development, clinical research, and delivery of low back total joint replacement.
  • 3Spine is headquartered in Chattanooga, TN, with research and development facilities in the Greater Boston area and clinical operations in the Cayman Islands.

The Rockefeller Foundation's Public Charity Expands Project ACT to Provide At-Risk Communities Nationwide with Free At-Home Covid-19 Tests

Retrieved on: 
Wednesday, June 29, 2022 - 6:08pm
ACT, National Alzheimer's Project Act, Science, Rockefeller Foundation, Michigan Department of Licensing and Regulatory Affairs, Kansas Department of Health and Environment, Kansas Department of Agriculture, COVID-19, Death, North Carolina Department of Health and Human Services, Program, Eligibility, Public health, Textbook, Michigander, South Carolina Department of Health and Environmental Control, New Mexico Department of Health, Risk, Partnership, Technology, Project, Environment, Health, Human services, NEW, RFCC, MD, State, Hispanic and Latino Americans, CDC, Amazon (company), Michigan Department of Health and Human Services, Pharmaceutical industry

NEW YORK, June 29, 2022 /PRNewswire/ -- The Rockefeller Foundation, through its public charity RF Catalytic Capital (RFCC), announced the nationwide expansion of Project Access Covid Tests (Project ACT) to provide free at-home Covid-19 tests directly to at-risk communities across the United States. After working with health departments in six states to deliver an initial one million tests, RFCC is opening up the program to all U.S. states and territories. Already, health departments in five states – Maine, New Mexico, Kansas, Michigan, and North Carolina – have signed up and committed funding to secure 1.2 million tests. Enrollment for health departments is open through August 31, 2022, with tests to be distributed through the end of February 2023.

Key Points: 
  • Enrollment for health departments is open through August 31, 2022, with tests to be distributed through the end of February 2023.
  • "Project ACT has successfully demonstrated this type of collaborative effort in action.
  • The Rockefeller Foundation provided the initial $7.45 million in January to pilot Project ACT.
  • "Partnering with Project ACT helps us improve access to testing, especially in our communities with historic lack of access to health care."

The International Consortium for Health Outcomes Measurement (ICHOM) will hold the largest gathering of value-based health care leaders in the world on 1-3 November 2022

Retrieved on: 
Wednesday, June 29, 2022 - 6:05pm
Department, Patient, CEO, Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital, World Economic Forum, Harvard Medical School, United States Department of Health and Human Services, Health care, Industry, Master of Science, Harvard Business School, Primary care physician, Hospital, BA, Office of the National Coordinator for Health Information Technology, Human services, Public health, Medicine, Risk management, Health, MD

Hundreds of healthcare stakeholders are expected to attend inperson, including providers, industry, life sciences, academia and patient representatives.

Key Points: 
  • Hundreds of healthcare stakeholders are expected to attend inperson, including providers, industry, life sciences, academia and patient representatives.
  • The programme will take place over three days with two key themes: Future Healthcare Systems and Healthcare Transformation Drivers.
  • There will be plenty of networking opportunities including an ICHOM welcome drinks reception, networking breakfasts and interactive conference sessions.
  • Is equitable and inclusive care possible without standardized outcomes measurement?

The International Consortium for Health Outcomes Measurement (ICHOM) will hold the largest gathering of value-based health care leaders in the world on 1-3 November 2022

Retrieved on: 
Wednesday, June 29, 2022 - 6:00pm
Department, Patient, CEO, Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital, World Economic Forum, Harvard Medical School, United States Department of Health and Human Services, Health care, Industry, Master of Science, Harvard Business School, Primary care physician, Hospital, BA, Office of the National Coordinator for Health Information Technology, Human services, Public health, Medicine, Risk management, Health, MD

Hundreds of healthcare stakeholders are expected to attend inperson, including providers, industry, life sciences, academia and patient representatives.

Key Points: 
  • Hundreds of healthcare stakeholders are expected to attend inperson, including providers, industry, life sciences, academia and patient representatives.
  • The programme will take place over three days with two key themes: Future Healthcare Systems and Healthcare Transformation Drivers.
  • There will be plenty of networking opportunities including an ICHOM welcome drinks reception, networking breakfasts and interactive conference sessions.
  • Is equitable and inclusive care possible without standardized outcomes measurement?

ACTIVE HEALTH FOODS, INC. COMPLETES “DREAM TEAM” BOARD OF DIRECTORS ADDING DRS. MILLER AND OLIVER

Retrieved on: 
Wednesday, June 29, 2022 - 6:03pm
OTC, Life, CEO, Bioidentical hormone replacement therapy, American Academy, Functional medicine, RBT, GLOBE, Bioenergetics, Association, Board of High School and Intermediate Education Uttar Pradesh, Empowerment, Founder, American Academy of Anti-Aging Medicine, Disorder, EMBA, CA, Transgender hormone therapy, Board, Physician, MD, BIO, Pharmaceutical industry, Director

Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.

Key Points: 
  • Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.
  • Dr. Miller has become a recognized leader in Anti-Aging integrative medicine.
  • This started with a past association with Dr. Julian Whitaker of the Whitaker Wellness Institute in Newport Beach, California.
  • He passed the first-ever Board Exams in Anti-Aging Medicine in December 1998. www.antiaging.com
    Dr. Aubrey Oliver, Functional Medicine Doctor, Naturopathic Doctor, RBT & EMBA, based in Jamaica.

Medzino Partners With Belle for AI-Powered Digital Skin Health

Retrieved on: 
Wednesday, June 29, 2022 - 5:43pm
Diagnosis, Acne, Dermatology, Patient, Nail disease, Vitiligo, Alopecia areata, Men's Health, Prescription, API, Melasma, Atopic dermatitis, District, Partnership, Technology, Psoriasis, Health, Physician, Skin, AI, Infection, Dermatitis, MD, Algorithm, Medical device, Medical imaging

AUSTIN, Texas and CAMBRIDGE, Mass., June 29, 2022 /PRNewswire/ -- Medzino Health and BelleTorus Corporation ("Belle") today announced Medzino's licensing of Belle's skin AI technology for Medzino's digital healthcare platform.

Key Points: 
  • AUSTIN, Texas and CAMBRIDGE, Mass., June 29, 2022 /PRNewswire/ -- Medzino Health and BelleTorus Corporation ("Belle") today announced Medzino's licensing of Belle's skin AI technology for Medzino's digital healthcare platform.
  • The Belle skin image matching engine is secure, cloud-based and HIPAA-compliant, and is provided via API integration into partners' websites.
  • Belle provides qualitative assessment (identification) and quantitative scoring (severity) of skin conditions, with applications available for providers, patient clinical trials, and skin health product companies.
  • Belle team members in the United States, France, and Vietnam collaborate with partners worldwide to bring the power of AI to digital skin healthcare.

ACTIVE HEALTH FOODS, INC. COMPLETES “DREAM TEAM” BOARD OF DIRECTORS ADDING DRS. AUBREY AND OLIVER

Retrieved on: 
Wednesday, June 29, 2022 - 3:45pm
OTC, Life, CEO, Bioidentical hormone replacement therapy, American Academy, Functional medicine, RBT, GLOBE, Bioenergetics, Association, Board of High School and Intermediate Education Uttar Pradesh, Empowerment, Founder, American Academy of Anti-Aging Medicine, Disorder, EMBA, CA, Transgender hormone therapy, Board, Physician, MD, BIO, Pharmaceutical industry, Director

Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.

Key Points: 
  • Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.
  • Dr. Miller has become a recognized leader in Anti-Aging integrative medicine.
  • This started with a past association with Dr. Julian Whitaker of the Whitaker Wellness Institute in Newport Beach, California.
  • He passed the first-ever Board Exams in Anti-Aging Medicine in December 1998. www.antiaging.com
    Dr. Aubrey Oliver, Functional Medicine Doctor, Naturopathic Doctor, RBT & EMBA, based in Jamaica.